Trial NCT04419181

View at ClinicalTrials.gov 
Org. Study IDs: UBRS20013

Last trial update was posted on 2023-10-06

MeSH Interventions

Ado-Trastuzumab Emtansine Carboplatin Docetaxel Maytansine Pertuzumab Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

HER2-positive Breast Cancer

Stopping Reasons

Change in the landscape of current treatment of early stage breast cancer. Larger clinical trials answering similar questions are expected to result in the next few years.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID